AB-MED: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
AB-MED
Largest movements
- Cash -€247,876
down €247,876 (-57.6%), from €430,621 to €182,745
mainly Other debts (-€404,184) and Contributions, distributions and other (-€205,000)
- Receivables within one year -€176,404
down €176,404 (-68.9%), from €256,019 to €79,615
of which Other amounts receivable: -€169,983
- Other debts -€404,184
down €404,184 (-62.7%), from €645,000 to €240,816
- Tax, wage and social debts -€12,660
down €12,660 (-90.4%), from €14,000 to €1,340
- Profit (loss) carried forward -€6,953
down €6,953 (-46.5%), from €14,964 to €8,011
- Financial income -€4,885
down €4,885 (-91.5%), from €5,338 to €454
- Gross operating margin -€4,102
down €4,102 (-1.6%), from €263,279 to €259,177
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €686,640 | €262,360 | -€424,280 | -61.8% |
| Current assets | 29/58 | €686,640 | €262,360 | -€424,280 | -61.8% |
| Amounts receivable within one year | 40/41 | €256,019 | €79,615 | -€176,404 | -68.9% |
| Trade receivables | 40 | €86,036 | €79,615 | -€6,421 | -7.5% |
| Other amounts receivable | 41 | €169,983 | - | -€169,983 | |
| Cash at bank and in hand | 54/58 | €430,621 | €182,745 | -€247,876 | -57.6% |
| Total equity and liabilities | 10/49 | €686,640 | €262,360 | -€424,280 | -61.8% |
| Equity | 10/15 | €19,964 | €13,011 | -€6,953 | -34.8% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €14,964 | €8,011 | -€6,953 | -46.5% |
| Amounts payable | 17/49 | €666,676 | €249,349 | -€417,327 | -62.6% |
| Amounts payable within one year | 42/48 | €666,152 | €249,349 | -€416,802 | -62.6% |
| Trade debts | 44 | €7,152 | €7,194 | +€42 | +0.6% |
| Suppliers | 440/4 | €7,152 | €7,194 | +€42 | +0.6% |
| Taxes, remuneration and social security | 45 | €14,000 | €1,340 | -€12,660 | -90.4% |
| Taxes | 450/3 | €14,000 | €1,340 | -€12,660 | -90.4% |
| Other amounts payable | 47/48 | €645,000 | €240,816 | -€404,184 | -62.7% |
| Accrued charges and deferred income | 492/3 | €524 | - | -€524 | |
| Other operating charges | 640/8 | €384 | €387 | +€3 | +0.8% |
| Gross operating margin | 9900 | €263,279 | €259,177 | -€4,102 | -1.6% |
| Operating profit (loss) | 9901 | €262,894 | €258,790 | -€4,105 | -1.6% |
| Financial income | 75/76B | €5,338 | €454 | -€4,885 | -91.5% |
| Recurring financial income | 75 | €5,338 | €454 | -€4,885 | -91.5% |
| Financial charges | 65/66B | €428 | €442 | +€14 | +3.2% |
| Recurring financial charges | 65 | €428 | €442 | +€14 | +3.2% |
| Profit (loss) for the period before taxes | 9903 | €267,805 | €258,802 | -€9,003 | -3.4% |
| Income taxes | 67/77 | €62,487 | €60,755 | -€1,732 | -2.8% |
| Profit (loss) for the period | 9904 | €205,318 | €198,047 | -€7,271 | -3.5% |
| Profit (loss) for the period to be appropriated | 9905 | €205,318 | €198,047 | -€7,271 | -3.5% |
Source: filed annual accounts (NBB), fiscal years ended 31 March 2024 and 31 March 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.